Cho-Hwa Liao

455 total citations
5 papers, 392 citations indexed

About

Cho-Hwa Liao is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Cho-Hwa Liao has authored 5 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Organic Chemistry and 1 paper in Pharmacology. Recurrent topics in Cho-Hwa Liao's work include Cancer therapeutics and mechanisms (1 paper), Inflammatory mediators and NSAID effects (1 paper) and Cell death mechanisms and regulation (1 paper). Cho-Hwa Liao is often cited by papers focused on Cancer therapeutics and mechanisms (1 paper), Inflammatory mediators and NSAID effects (1 paper) and Cell death mechanisms and regulation (1 paper). Cho-Hwa Liao collaborates with scholars based in Taiwan and United States. Cho-Hwa Liao's co-authors include Agnieszka Czechowicz, G‐One Ahn, Diane Tseng, Mary J. Dorie, J. Martin Brown, Che‐Jen Hsiao, Tsai‐Kun Li, Ping‐Chiang Lyu, Jih‐Hwa Guh and Shih‐Chieh Chueh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Cancer Research and Biochemical Pharmacology.

In The Last Decade

Cho-Hwa Liao

4 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cho-Hwa Liao Taiwan	3	186	176	122	56	44	5	392
Padmini Jayaraman United States	9	275 1.5×	181 1.0×	200 1.6×	86 1.5×	41 0.9×	11	545
Marie-Anne Goyette Canada	11	179 1.0×	193 1.1×	188 1.5×	64 1.1×	53 1.2×	15	457
Alexis S. Lopez United States	6	86 0.5×	170 1.0×	226 1.9×	103 1.8×	98 2.2×	8	495
Nader Tawakkol United States	2	114 0.6×	369 2.1×	250 2.0×	134 2.4×	44 1.0×	3	503
Touko Inao Japan	12	145 0.8×	280 1.6×	184 1.5×	106 1.9×	71 1.6×	20	495
Jianqun Liao United States	10	137 0.7×	257 1.5×	340 2.8×	149 2.7×	37 0.8×	14	642
Ahmed A. Quraishi United States	3	102 0.5×	385 2.2×	281 2.3×	148 2.6×	39 0.9×	4	529
Emily A. Xue United States	2	101 0.5×	212 1.2×	150 1.2×	115 2.1×	43 1.0×	4	381
Shauntae M. McDaniel United States	7	64 0.3×	306 1.7×	212 1.7×	120 2.1×	33 0.8×	7	519
Militsa Rakina Russia	8	235 1.3×	156 0.9×	157 1.3×	80 1.4×	50 1.1×	12	410

Countries citing papers authored by Cho-Hwa Liao

Since Specialization

Citations

This map shows the geographic impact of Cho-Hwa Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cho-Hwa Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cho-Hwa Liao more than expected).

Fields of papers citing papers by Cho-Hwa Liao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cho-Hwa Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cho-Hwa Liao. The network helps show where Cho-Hwa Liao may publish in the future.

Co-authorship network of co-authors of Cho-Hwa Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Cho-Hwa Liao. A scholar is included among the top collaborators of Cho-Hwa Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cho-Hwa Liao. Cho-Hwa Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Ahn, G‐One, Diane Tseng, Cho-Hwa Liao, et al.. (2010). Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proceedings of the National Academy of Sciences. 107(18). 8363–8368. 296 indexed citations

2.

Guh, Jih‐Hwa, Shiow‐Lin Pan, Cho-Hwa Liao, et al.. (2007). YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activating JNK pathway. Clinical Cancer Research. 13.

3.

Chueh, Shih‐Chieh, Che‐Jen Hsiao, Tsai‐Kun Li, et al.. (2007). Prazosin Displays Anticancer Activity against Human Prostate Cancers: Targeting DNA, Cell Cycle. Neoplasia. 9(10). 830–839. 60 indexed citations

4.

Hsiao, Che‐Jen, Tsai‐Kun Li, Ling‐Wei Hsin, et al.. (2007). WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: Identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers. Biochemical Pharmacology. 75(4). 847–856. 34 indexed citations

5.

Liao, Chang‐Hui, Cho-Hwa Liao, Ya‐Ling Chang, et al.. (2002). Effect of a potent cyclooxygenase inhibitor, 5-ethyl-4-methoxy-2-phenylquinoline (KTC-5), on human platelets. Journal of Pharmacy and Pharmacology. 54(7). 967–973. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact